Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETIC perioperative endocrine therapy trial in early hormone receptor-positive breast cancer
ISRCTN63882543Phase 3Active, not recruiting
- Sponsor
- The Institute of Cancer Research
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in breast cancer comparing Anastrozole with Letrozole (2 arms). Primary endpoint: Relapse-free survival. Started Aug 2008; status: active, not recruiting.
02
Drugs
anastrozoleletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN63882543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63882543.